KR910007540A - 혈구 감소 장해의 예방ㆍ치료제 - Google Patents
혈구 감소 장해의 예방ㆍ치료제 Download PDFInfo
- Publication number
- KR910007540A KR910007540A KR1019900015403A KR900015403A KR910007540A KR 910007540 A KR910007540 A KR 910007540A KR 1019900015403 A KR1019900015403 A KR 1019900015403A KR 900015403 A KR900015403 A KR 900015403A KR 910007540 A KR910007540 A KR 910007540A
- Authority
- KR
- South Korea
- Prior art keywords
- prevention
- treatment
- blood cell
- cell reduction
- gly
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
Abstract
내용 없음.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (1)
- 하기의 아미노산 배열pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn을 가진 노나펩티드 또는, 그 C말단의 아스파라긴의 카르복실기에서의 에스테르, 아미드 또는, 그들 각 화합물의 약학적으로 허용할수 있는 염 또는 그 각 화합물과 금속과의 결합물을 유효성분으로서 함유하는 것을 특징으로 하는 각종 혈구의 감소 장애의 예방·치료제.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1-257729 | 1989-10-04 | ||
JP25772989 | 1989-10-04 | ||
JP257729 | 1989-10-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR910007540A true KR910007540A (ko) | 1991-05-30 |
KR930001304B1 KR930001304B1 (ko) | 1993-02-25 |
Family
ID=17310285
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019900015403A KR930001304B1 (ko) | 1989-10-04 | 1990-09-27 | 혈구 감소 장해의 예방·치료제 |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0425828A3 (ko) |
KR (1) | KR930001304B1 (ko) |
CA (1) | CA2026306A1 (ko) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2962335B1 (fr) | 2010-07-12 | 2013-01-18 | Cll Pharma | Utilisation du nonapeptide pat dans le traitement et la prevention des maladies neurodegeneratives |
US9468662B2 (en) | 2010-07-12 | 2016-10-18 | Orphit | Use of the PAT nonapeptide in the treatment and prevention of neurodegenerative diseases |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1572889A (en) * | 1977-05-25 | 1980-08-06 | Inst Nat Sante Rech Med | Polypeptides |
JPS54148722A (en) * | 1978-05-12 | 1979-11-21 | Takeda Chem Ind Ltd | Nonapeptide and its preparation |
KR920002700B1 (ko) * | 1988-04-04 | 1992-03-31 | 미쓰이 도오아쓰 카가쿠 가부시끼가이샤 | 방사선 장해 방호제(防護劑) |
-
1990
- 1990-09-26 CA CA002026306A patent/CA2026306A1/en not_active Abandoned
- 1990-09-27 KR KR1019900015403A patent/KR930001304B1/ko not_active IP Right Cessation
- 1990-10-03 EP EP19900118901 patent/EP0425828A3/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP0425828A2 (en) | 1991-05-08 |
CA2026306A1 (en) | 1991-04-05 |
KR930001304B1 (ko) | 1993-02-25 |
EP0425828A3 (en) | 1991-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68919146D1 (de) | Ausgewählte Stämme von Lactobacillus enthaltende pharmazeutische Zusammensetzungen. | |
ATE50493T1 (de) | Ibuprofen enthaltendes arzneimittel. | |
CA2029524A1 (en) | Transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole | |
GT199800126A (es) | Terapia de combinacion. | |
KR870005637A (ko) | 약물 데포 | |
IT8621358A0 (it) | Composizione farmaceutica adattivita' analgesica. | |
KR850007208A (ko) | 약산성욕 염조성물 | |
FI875272A (fi) | Baerarloesningsmedelssystem i tvao fas. | |
KR910000703A (ko) | 테트라졸 자극성 아미노산 수용체의 길항물질 | |
KR890004680A (ko) | 좌 약 | |
IT8820048A0 (it) | Telestampa presso un utente sistema e apparecchiatura di telefonico di informazione provenienti da enti di pubblica utilita', o simili, conpossibilita' di interazione e suoi metodi di realizzazione e di utilizzazione. | |
RU94002133A (ru) | 6-хлор-5-фтор-3-(2-теноил)-2-оксиндол-1-карбоксамид как аналгезирующее и противовоспалительное средство | |
DK0498144T3 (da) | Anvendelse af acetyl-L-carnitin ved terapeutisk behandling af coma | |
ES2171444T3 (es) | Una solucion intravenosa que disminuye las perdidas de proteinas y de agua corporales. | |
KR950032272A (ko) | L-리실-글리실-l-히스티딘 및 이를 함유하는 창상 유합용 치료제 | |
KR920703050A (ko) | 골형성 촉진제 | |
KR910007540A (ko) | 혈구 감소 장해의 예방ㆍ치료제 | |
DE3867086D1 (de) | Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen. | |
KR910009267A (ko) | 우울증의 치료방법 | |
TR199801184T2 (xx) | Analjezik tesirli yeni bile�ikler. | |
KR970061248A (ko) | 알츠하이머병 치료용 1, 1, 2-트리페닐부트-1-엔 유도체 | |
DK0437225T3 (da) | Topiske præparater | |
RS49520B (sr) | Antimikrobno aktivne smeše | |
FR2684552B1 (fr) | Utilisation de la d-fenfluramine et de derives de la fenfluramine dans le traitement de l'hypertension chez des sujets insulino-resistants. | |
DE69208681T2 (de) | Verwendungen von 1,1,1,3,3,3-hexafluoropropan |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |